Mar 24, 2017 7:05am EDT Immunovaccine to Present New Pre-clinical Combination Therapy Data at the AACR Annual Meeting
Feb 06, 2017 7:05am EST Immunovaccine's Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug
Nov 22, 2016 7:05am EST The European Medicines Agency Grants Orphan Drug Designation Status to Immunovaccine's DPX-Survivac in Ovarian Cancer
Nov 08, 2016 5:05pm EST Immunovaccine Announces Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 03, 2016 7:05am EDT Neoepitope Peptides Formulated in Immunovaccine's DepoVax(TM) Vaccine Platform Show Significant Positive Results in Preclinical Studies
Nov 01, 2016 7:05am EDT Immunovaccine Appoints Gabriela Rosu, M.D., as Company's First Chief Medical Officer